Tenax Therapeutics

NEWS

Business

BioSpace Movers & Shakers, Feb. 4

Biopharma and life sciences companies strengthen their boards and leadership teams with these Movers & Shakers.

February 3, 2022

9 min read

Alex Keown

Business

New CEOs Named at Two Biopharma Companies

Scorpion Therapeutics announced its new CEO Dr. Axel Hoos while Tenax Therapeutics named Christopher Giordano as its new chief executive.

July 8, 2021

2 min read

Vanessa Doctor, RN

IN THE PRESS

Bio NC

Oxygen Biotherapeutics, Inc. Announces it Will Present at the 15th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference on February 11

January 31, 2013

1 min read

Bio NC

Oxygen Biotherapeutics, Inc. Announces it Will Present at the 15th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference on February 11

January 30, 2013

1 min read

Bio NC

Oxygen Biotherapeutics, Inc. Announces it Will Present at OneMedForum Conference on Wednesday January 9th

January 9, 2013

1 min read

Business

Oxygen Biotherapeutics, Inc. Reports Second Quarter FY2013 Financial Results

December 17, 2012

1 min read

Business

Oxygen Biotherapeutics, Inc. Announces Second Quarter FY2013 Financial Results Conference Call and Webcast

December 7, 2012

1 min read

Drug Development

Oxygen Biotherapeutics, Inc. Engages PPD to Execute Remainder of Phase IIb Clinical Trial to Evaluate the Safety and Tolerability of Oxycyte® in Severe Traumatic Brain Injury

November 20, 2012

1 min read

Drug Development

Oxygen Biotherapeutics, Inc.’ Update on US Army-Funded Preclinical Studies Designed to Support the Safety Profile of Oxycyte PFC Emulsion Currently in Clinical Trials Overseas for Traumatic Brain Injury

October 25, 2012

1 min read

Business

Oxygen Biotherapeutics, Inc. Signs Cooperative Research and Development Agreement With U.S. Navy to Investigate the Use of Oxycyte PFC Emulsion as an Adjunctive Treatment of Complex Infected Wounds and Related Injuries

October 3, 2012

1 min read

Bio NC

Oxygen Biotherapeutics, Inc. Could Face Delisting

September 24, 2012

1 min read

Business

Oxygen Biotherapeutics, Inc. Reports First Quarter FY2013 Financial Results

September 20, 2012

1 min read

JOBS